Laurent Sutton
Overview
Explore the profile of Laurent Sutton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
651
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Algrin C, Perol L, Chapiro E, Baseggio L, Maloum K, Settegrana C, et al.
Haematologica
. 2022 Dec;
108(6):1691-1696.
PMID: 36546425
No abstract available.
2.
Johnson-Ansah H, Maneglier B, Huguet F, Legros L, Escoffre-Barbe M, Gardembas M, et al.
Pharmaceutics
. 2022 Aug;
14(8).
PMID: 36015302
The registered dose for imatinib is 400 mg/d, despite high inter-patient variability in imatinib plasmatic exposure. Therapeutic drug monitoring (TDM) is routinely used to maximize a drug’s efficacy or tolerance....
3.
Chalopin T, Vallet N, Morel M, Maguet R, DAlteroche L, De Pinieux G, et al.
J Med Case Rep
. 2021 Mar;
15(1):135.
PMID: 33722291
Background: Shulman's disease, or eosinophilic fasciitis (EF), is a rare autoimmune disease, characterized by sclerodermic skin lesions with progressive induration and thickening of the soft tissues. Chronic graft-versus-host-disease (GVHD) presenting...
4.
Roos-Weil D, Nguyen-Khac F, Chevret S, Touzeau C, Roux C, Lejeune J, et al.
Genes Chromosomes Cancer
. 2018 Sep;
57(11):533-540.
PMID: 30203893
Trisomy 12 (tri12) is the second most frequent chromosomal aberration (15%-20%) in chronic lymphocytic leukemia (CLL). Tri12 confers an intermediate prognosis but is a heterogeneous entity. We examined whether additional...
5.
Loiseau C, Lemonnier F, Randrianarivelo O, Itzykson R, Nguyen S, Becquemin M, et al.
Eur Respir J
. 2018 May;
52(1).
PMID: 29794130
No abstract available.
6.
Chapiro E, Lesty C, Gabillaud C, Durot E, Bouzy S, Armand M, et al.
Am J Hematol
. 2017 Dec;
93(3):375-382.
PMID: 29194741
Chronic lymphocytic leukemia (CLL) with 17p deletion (17p-) is associated with a lack of response to standard treatment and thus the worst possible clinical outcome. Various chromosomal abnormalities (including unbalanced...
7.
Durot E, Tomowiak C, Michallet A, Dupuis J, Hivert B, Lepretre S, et al.
Br J Haematol
. 2017 Aug;
179(3):439-448.
PMID: 28770576
Histological transformation (HT) to diffuse large B-cell lymphoma (DLBCL) is a rare and poorly reported complication of Waldenström macroglobulinaemia (WM). We performed a retrospective study of 77 WM patients with...
8.
Rousselot P, Coude M, Gokbuget N, Passerini C, Hayette S, Cayuela J, et al.
Blood
. 2016 Apr;
128(6):774-82.
PMID: 27121472
Prognosis of Philadelphia-positive (Ph(+)) acute lymphoblastic leukemia (ALL) in the elderly has improved during the imatinib era. We investigated dasatinib, another potent tyrosine kinase inhibitor, in combination with low-intensity chemotherapy....
9.
Bond J, Marchand T, Touzart A, Cieslak A, Trinquand A, Sutton L, et al.
Haematologica
. 2016 Mar;
101(6):732-40.
PMID: 26944475
Unlabelled: Gene expression studies have consistently identified a HOXA-overexpressing cluster of T-cell acute lymphoblastic leukemias, but it is unclear whether these constitute a homogeneous clinical entity, and the biological consequences...
10.
Genet P, Sutton L, Chaoui D, Al Jijakli A, Gerbe J, Masse V, et al.
J Int AIDS Soc
. 2014 Nov;
17(4 Suppl 3):19649.
PMID: 25394153
Introduction: In non-HIV patients, Monoclonal Gammopathy of Undetermined Significance (MGUS) is associated with an increased risk of subsequent development of haematologic malignancies, especially multiple myeloma (MM) and it has been...